Target Price | $7.33 |
Price | $3.75 |
Potential |
95.56%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target BioNano Genomics, Inc. 2026 .
The average BioNano Genomics, Inc. target price is $7.33.
This is
95.56%
register free of charge
$10.00
166.67%
register free of charge
$4.00
6.67%
register free of charge
|
|
A rating was issued by 4 analysts: 2 Analysts recommend BioNano Genomics, Inc. to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the BioNano Genomics, Inc. stock has an average upside potential 2026 of
95.56%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 30.78 | 30.21 |
14.78% | 1.84% | |
EBITDA Margin | -226.38% | -44.19% |
37.47% | 80.48% | |
Net Margin | -363.94% | -63.99% |
43.46% | 82.42% |
4 Analysts have issued a sales forecast BioNano Genomics, Inc. 2025 . The average BioNano Genomics, Inc. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an BioNano Genomics, Inc. EBITDA forecast 2025. The average BioNano Genomics, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 BioNano Genomics, Inc. Analysts have issued a net profit forecast 2025. The average BioNano Genomics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -88.13 | -6.24 |
1,194.13% | 92.92% | |
P/E | negative | |
EV/Sales | negative |
3 Analysts have issued a BioNano Genomics, Inc. forecast for earnings per share. The average BioNano Genomics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
BioNano Genomics, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Maxim Group |
Locked
➜
Locked
|
Locked | May 20 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
Scotiabank |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
Ladenburg Thalmann |
Locked
➜
Locked
|
Locked | Nov 15 2024 |
BTIG |
Locked
➜
Locked
|
Locked | Sep 10 2024 |
Scotiabank |
Locked
➜
Locked
|
Locked | Aug 28 2024 |
Analyst Rating | Date |
---|---|
Locked
Maxim Group:
Locked
➜
Locked
|
May 20 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 09 2025 |
Locked
Scotiabank:
Locked
➜
Locked
|
Apr 02 2025 |
Locked
Ladenburg Thalmann:
Locked
➜
Locked
|
Nov 15 2024 |
Locked
BTIG:
Locked
➜
Locked
|
Sep 10 2024 |
Locked
Scotiabank:
Locked
➜
Locked
|
Aug 28 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.